
Indoco Remedies Limited has informed the Exchange regarding a press release dated May 21, 2024, titled "Indoco Remedies receives final ANDA approval from USFDA for Pregabalin capsules".
Filed with NSE ·

Indoco Remedies Limited has informed the Exchange regarding a press release dated May 21, 2024, titled "Indoco Remedies receives final ANDA approval from USFDA for Pregabalin capsules".
6ix hasn’t read this filing yet.
Indoco Remedies Limited on 6ix
Follow Indoco Remedies into a list and get an email when it puts out news.
Follow Indoco Remedies